Windtree Therapeutics, Inc. (WINT) Reports Q4 Loss of $0.77
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500, Nasdaq rise as tech stocks gain ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts WINT Hot Sheet
Join SI Premium – FREE
Windtree Therapeutics, Inc. (NASDAQ: WINT) reported Q4 EPS of ($0.77), versus ($1.26) reported last year.
For earnings history and earnings-related data on Windtree Therapeutics, Inc. (WINT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Tigress Financial Partners Reiterates Buy Rating on Jersey Mike's Subs (JMKE)
- Syra Health Corp. (SYRA) Reports Q3 EPS of $0.02
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
